Search Results

Next Horizons: Interventional Neuro-Oncology

A look at the expanding role of interventional oncology for central nervous system and head and neck cancers.

By Stephen Chen, MD, and Peter Kan, MD, MPH, FRCSC, FAANS

Exploring New Dimensions of Interventional Oncology

By Rahul A. Sheth, MD, and Alda L. Tam, MD, MBA, FSIR

Arch Debranching Is Best

Without sufficient long-term data on the use of chimney or branched grafts, arch debranching is the preferred treatment modality.

By Stephen W. K. Cheng, MD

Essential Innovation and Clinical Trial Needs in Vascular Care

Experts from a variety of specialty backgrounds comment on hurdles and opportunities for future clinical trials to explore.

With Kendal M. Endicott, MD; Jessica P. Simons, MD, MPH; Abinaya Ramakrishnan, BA; Salma Youssef; Mona Ranade, MD; John M. Moriarty, MD, FSIR; Peter A. Schneider, MD; Amy C. Taylor, MD; Sarah B. White, MD, MS, FSIR, FCIRSE; Stephen A. Black, MD, FRCS(Ed), FEBVS; Kunal P. Raygor, MD; Mehdi Bouslama, MD, MSc; and Elad I. Levy, MD, MBA

Charting a Course: The Future of Neurointervention

By Brian P. Walcott, MD, and William J. Mack, MD

Current Status of EVAR in Hong Kong

By Stephen W.K. Cheng, MS, FRCS, FRCS (Ed), FACS

Panel Discussion: What Attributes Are Necessary for the Ideal Branch Stent?

Characteristics of and challenges to designing an ideal branch stent and how it could be achieved.

With Matthew J. Eagleton, MD; Sanghyun Ahn, MD; Javairiah Fatima, MD, FACS, DFSVS; Stephen W.K. Cheng, MS, FRCS, FRCS(Ed), FACS; Martin J. Austermann, MD, PhD; Nuno V. Dias, MD, PhD; and Björn Sonesson, MD

Update on Modern Complex Abdominal Aortic Repair Options

Current endovascular solutions for complex aortic disease, highlighting design and clinical experience.

With Jason T. Lee, MD; Steven Maximus, MD, FACS; Gustavo Oderich, MD, FACS; Benjamin W. Starnes, MD, FACS; Carlos Timaran, MD; Kak Khee Yeung, MD, PhD, FEBVS; and Javairiah Fatima, MD, FACS, DFSVS

Does Difficult Iliac Access Still Exist?

EVAR device profiles are getting smaller, and access techniques are becoming more refined, but are we there yet?

By Yiu Che Chan, MB BS, BSc, MD, FRCS (Eng), FRCS (Gen Surg) FCSHK, and Stephen W. K. Cheng, MB BS, MS, FRCS (Eng), FRCS (Edin), FCSHK, FHKAM

Chief Medical Editor's Page

More EVAR Options, But Also More Questions

By Ronald M. Fairman, MD, and Edward Y. Woo, MD

Trends in TEVAR

By Edward Y. Woo, MD, and Ian M. Loftus, MD, FRCS

Endovascular Advances in the Treatment of Cerebral Aneurysms

An overview of the development of new neuroendovascular techniques and technology for the treatment of cerebral aneurysms.

By Stephan A. Munich, MD, and Michael Chen, MD

The Continued Evolution of Neurointervention

By Michael Chen, MD

Cataract Development in Vascular Intervention

An analysis of risk and the appropriate preventive measures.

By Kevin Seals, MD; Harry Trieu, BS; Stephen Kee, MD; and Edward Wolfgang Lee, MD, PhD